{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,19]],"date-time":"2026-08-19T21:26:44Z","timestamp":1787174804189,"version":"build-2736575974"},"reference-count":45,"publisher":"Oxford University Press (OUP)","issue":"6","license":[{"start":{"date-parts":[[2023,1,7]],"date-time":"2023-01-07T00:00:00Z","timestamp":1673049600000},"content-version":"vor","delay-in-days":37,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"},{"start":{"date-parts":[[2022,9,4]],"date-time":"2022-09-04T00:00:00Z","timestamp":1662249600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"},{"start":{"date-parts":[[2022,12,1]],"date-time":"2022-12-01T00:00:00Z","timestamp":1669852800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/doi.wiley.com\/10.1002\/tdm_license_1.1"}],"content-domain":{"domain":["onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2022,12,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Pain is the most common and bothersome symptom experienced by people with hidradenitis suppurativa (HS) and has been prioritized as an outcome domain by the HIdradenitis SuppuraTiva cORe outcomes set International Collaboration (HISTORIC).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Objectives<\/jats:title>\n                    <jats:p>To perform a scoping review of pain measurement in randomized control trials (RCTs) of painful skin conditions (PSCs) and use of the pain numerical rating scale (NRS) and visual analogue scale (VAS) in rheumatoid arthritis RCTs, to inform the efforts of HISTORIC to reach consensus on how to measure pain intensity in HS trials.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>A search was conducted on several publication databases. Inclusion criteria were RCTs with a minimum of 10 participants that measured pain intensity.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Pain NRS and VAS were used in 68% of PSC trials. Respectively, 77% and 87% of PSC and rheumatoid arthritis RCTs did not specify the recall window. The commonest recall window in PSCs when specified was 24 h. In total, 33% of PSC trials assessed maximum pain intensity and 3% average pain intensity, while 87% of rheumatoid arthritis trials did not provide details. Pain data were reported as mean difference by 76% of PSC trials and 75% of rheumatoid arthritis trials. Respectively, 10% and 11% of PSC and rheumatoid arthritis studies reported pain as the percentage of patients reaching a desirable state and only 1% and 2% reported number needed to treat.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>While pain NRS and VAS are standard methods to measure pain intensity in PSCs, key details such as the recall window are often omitted and there is no consensus on how to report pain NRS data.<\/jats:p>\n                    <jats:p>What is already known about this topic? \u00a0Pain is the most burdensome symptom experienced by patients with hidradenitis suppurativa and has been prioritized as an outcome domain by the HIdradenitis SuppuraTiva cORe outcomes set International Collaboration (HISTORIC).<\/jats:p>\n                    <jats:p>What does this study add? \u00a0Our review shows substantial variation in how pain numerical rating scale (NRS) and visual analogue scale are utilized in clinical trials. This variation restricts meta-analysis of pain intensity results.There is a need for consensus regarding the recall window for pain NRS and maximum vs. average pain, and whether current pain should be measured.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1111\/bjd.21821","type":"journal-article","created":{"date-parts":[[2022,8,13]],"date-time":"2022-08-13T02:28:26Z","timestamp":1660357706000},"page":"846-854","update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":14,"title":["Pain measurement in painful skin conditions and rheumatoid arthritis randomized controlled trials: a scoping review to inform pain measurement in hidradenitis suppurativa"],"prefix":"10.1093","volume":"187","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-3265-4530","authenticated-orcid":false,"given":"Samar B.","family":"Hasan","sequence":"first","affiliation":[{"name":"Division of Infection & Immunity Cardiff University Cardiff UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0298-7115","authenticated-orcid":false,"given":"Riham","family":"Gendra","sequence":"additional","affiliation":[{"name":"Division of Infection & Immunity Cardiff University Cardiff UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"JaBreia","family":"James","sequence":"additional","affiliation":[{"name":"BS Medical College of Georgia Augusta GA USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Delyth","family":"Morris","sequence":"additional","affiliation":[{"name":"University Library Service, Cardiff University Cardiff UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0534-2854","authenticated-orcid":false,"given":"Lauren A.V.","family":"Orenstein","sequence":"additional","affiliation":[{"name":"Dermatology Department Emory University Atlanta GA USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5257-1142","authenticated-orcid":false,"given":"John R.","family":"Ingram","sequence":"additional","affiliation":[{"name":"Division of Infection & Immunity Cardiff University Cardiff UK"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2022,12,1]]},"reference":[{"key":"2023010808111344800_bjd21821-bib-0001","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1016\/S0190-9622(96)90321-7","article-title":"The prevalence of hidradenitis suppurativa and its potential precursor lesions","volume":"35","author":"Jemec","year":"1996","journal-title":"J Am Acad Dermatol"},{"issue":"Suppl. 2","key":"2023010808111344800_bjd21821-bib-0002","doi-asserted-by":"crossref","first-page":"S165","DOI":"10.1016\/j.jid.2016.06.043","article-title":"Hidradenitis suppurativa prevalence and disease associations using the Clinical Practice Research Datalink","volume":"136","author":"Ingram","year":"2016","journal-title":"J Invest Dermatol"},{"key":"2023010808111344800_bjd21821-bib-0003","doi-asserted-by":"crossref","first-page":"884","DOI":"10.1111\/bjd.12787","article-title":"The prevalence of inverse recurrent suppuration: a population-based study of possible hidradenitis suppurativa","volume":"170","author":"Vinding","year":"2014","journal-title":"Br J Dermatol"},{"key":"2023010808111344800_bjd21821-bib-0004","doi-asserted-by":"crossref","first-page":"596","DOI":"10.1016\/j.jaad.2008.06.020","article-title":"Prevalence and factors associated with hidradenitis suppurativa: results from two case\u2013control studies","volume":"59","author":"Revuz","year":"2008","journal-title":"J Am Acad Dermatol"},{"key":"2023010808111344800_bjd21821-bib-0005","doi-asserted-by":"crossref","first-page":"809","DOI":"10.1046\/j.1365-2133.2001.04137.x","article-title":"Morbidity in patients with hidradenitis suppurativa","volume":"144","author":"Von Der Werth","year":"2001","journal-title":"Br J Dermatol"},{"key":"2023010808111344800_bjd21821-bib-0006","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1159\/000358009","article-title":"Self-reported skin morbidities and health-related quality of life: a population-based nested case\u2013control study","volume":"228","author":"Vinding","year":"2014","journal-title":"Dermatology"},{"key":"2023010808111344800_bjd21821-bib-0007","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1016\/j.jid.2017.09.008","article-title":"Increased suicide risk in patients with hidradenitis suppurativa","volume":"138","author":"Thorlacius","year":"2018","journal-title":"J Invest Dermatol"},{"key":"2023010808111344800_bjd21821-bib-0008","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1016\/j.jaad.2019.06.1301","article-title":"Evaluating patients\u2019 unmet needs in hidradenitis suppurativa: results from the Global Survey Of Impact and Healthcare Needs (VOICE) Project","volume":"82","author":"Garg","year":"2020","journal-title":"J Am Acad Dermatol"},{"issue":"Suppl. 1","key":"2023010808111344800_bjd21821-bib-0009","article-title":"Patients\u2019 experiences with hidradenitis suppurativa: a qualitative study of symptoms and impacts","volume":"68","author":"Kimball","year":"2013","journal-title":"J Am Acad Dermatol"},{"key":"2023010808111344800_bjd21821-bib-0010","doi-asserted-by":"crossref","first-page":"642","DOI":"10.1111\/bjd.16672","article-title":"A core domain set for hidradenitis suppurativa trial outcomes: an international Delphi process","volume":"179","author":"Thorlacius","year":"2018","journal-title":"Br J Dermatol"},{"issue":"Suppl. 1","key":"2023010808111344800_bjd21821-bib-0011","doi-asserted-by":"crossref","first-page":"S47","DOI":"10.1016\/j.jaad.2015.07.046","article-title":"Pain management in patients with hidradenitis suppurativa","volume":"73","author":"Horv\u00e1th","year":"2015","journal-title":"J Am Acad Dermatol"},{"key":"2023010808111344800_bjd21821-bib-0012","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1016\/j.jaad.2020.09.039","article-title":"Pain management in hidradenitis suppurativa and a proposed treatment algorithm","volume":"85","author":"Savage","year":"2021","journal-title":"J Am Acad Dermatol"},{"key":"2023010808111344800_bjd21821-bib-0013","doi-asserted-by":"crossref","first-page":"20616","DOI":"10.5070\/D31911020616","article-title":"Treatment of hidradenitis suppurativa associated pain with nonsteroidal anti-inflammatory drugs, acetaminophen, celecoxib, gabapentin, pegabalin, duloxetine, and venlafaxine","volume":"19","author":"Scheinfeld","year":"2013","journal-title":"Dermatol Online J"},{"key":"2023010808111344800_bjd21821-bib-0014","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1001\/jamadermatol.2020.5857","article-title":"Expert knowledge, attitudes, and practices in management of hidradenitis suppurativa pain","volume":"157","author":"Jedrzejczak","year":"2021","journal-title":"JAMA Dermatol"},{"key":"2023010808111344800_bjd21821-bib-0015","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1111\/bjd.18692","article-title":"The Hidradenitis Suppurativa Quality of Life (HiSQOL) score: development and validation of a measure for clinical trials","volume":"183","author":"Kirby","year":"2020","journal-title":"Br J Dermatol"},{"key":"2023010808111344800_bjd21821-bib-0016","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/j.pmn.2010.12.003","article-title":"The McGill Pain Questionnaire as a multidimensional measure in people with cancer: an integrative review","volume":"13","author":"Ngamkham","year":"2012","journal-title":"Pain Manage Nurs"},{"key":"2023010808111344800_bjd21821-bib-0017","doi-asserted-by":"crossref","first-page":"108","DOI":"10.4103\/0973-1075.84531","article-title":"Utilization of brief pain inventory as an assessment tool for pain in patients with cancer: a focused review","volume":"17","author":"Kumar","year":"2011","journal-title":"Indian J Palliat Care"},{"key":"2023010808111344800_bjd21821-bib-0018","doi-asserted-by":"crossref","first-page":"1073","DOI":"10.1016\/j.jpainsymman.2010.08.016","article-title":"Studies comparing numerical rating scales, verbal rating scales, and visual analogue scales for assessment of pain intensity in adults: a systematic literature review","volume":"41","author":"Hjermstad","year":"2011","journal-title":"J Pain Symptom Manage"},{"key":"2023010808111344800_bjd21821-bib-0019","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.pain.2004.09.012","article-title":"Core outcome measures for chronic pain clinical trials: IMMPACT recommendations","volume":"113","author":"Dworkin","year":"2005","journal-title":"Pain"},{"key":"2023010808111344800_bjd21821-bib-0020","doi-asserted-by":"crossref","first-page":"1009","DOI":"10.1111\/bjd.17537","article-title":"British Association of Dermatologists guidelines for the management of hidradenitis suppurativa (acne inversa) 2018","volume":"180","author":"Ingram","year":"2019","journal-title":"Br J Dermatol"},{"key":"2023010808111344800_bjd21821-bib-0021","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1177\/1203475417716117","article-title":"Approach to the management of patients with hidradenitis suppurativa: a consensus document","volume":"21","author":"Alavi","year":"2017","journal-title":"J Cutan Med Surg"},{"key":"2023010808111344800_bjd21821-bib-0022","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1111\/jdv.12966","article-title":"European S1 guideline for the treatment of hidradenitis suppurativa\/acne inversa","volume":"29","author":"Zouboulis","year":"2015","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"2023010808111344800_bjd21821-bib-0023","doi-asserted-by":"crossref","first-page":"1962","DOI":"10.3899\/jrheum.141440","article-title":"Optimal strategies for reporting pain in clinical trials and systematic reviews: recommendations from an OMERACT 12 workshop","volume":"42","author":"Busse","year":"2015","journal-title":"J Rheumatol"},{"key":"2023010808111344800_bjd21821-bib-0024","doi-asserted-by":"crossref","first-page":"970","DOI":"10.1111\/bjd.14418","article-title":"Interventions for hidradenitis suppurativa: a Cochrane systematic review incorporating GRADE assessment of evidence quality","volume":"174","author":"Ingram","year":"2016","journal-title":"Br J Dermatol"},{"key":"2023010808111344800_bjd21821-bib-0025","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1111\/j.1365-2230.2008.02789.x","article-title":"A systematic review of randomized controlled trials of treatments for inherited forms of epidermolysis bullosa","volume":"34","author":"Langan","year":"2009","journal-title":"Clin Exp Dermatol"},{"key":"2023010808111344800_bjd21821-bib-0026","first-page":"290","article-title":"Effectiveness of systemic treatments for pyoderma gangrenosum: a systematic review of observational studies and clinical trials","volume":"179","author":"Partridge","year":"2018","journal-title":"Br J Dermatol"},{"key":"2023010808111344800_bjd21821-bib-0027","doi-asserted-by":"crossref","first-page":"903","DOI":"10.1016\/j.jaad.2010.04.039","article-title":"A systematic review of randomized controlled trials for pemphigus vulgaris and pemphigus foliaceus","volume":"64","author":"Martin","year":"2011","journal-title":"J Am Acad Dermatol"},{"key":"2023010808111344800_bjd21821-bib-0028","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1016\/j.jpain.2005.09.012","article-title":"Recalled pain ratings: a complex and poorly defined task","volume":"7","author":"Broderick","year":"2006","journal-title":"J Pain"},{"key":"2023010808111344800_bjd21821-bib-0029","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1016\/0304-3959(93)90148-I","article-title":"Increasing the reliability and validity of pain intensity measurement in chronic pain patients","volume":"55","author":"Jensen","year":"1993","journal-title":"Pain"},{"key":"2023010808111344800_bjd21821-bib-0030","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1016\/j.clon.2007.04.007","article-title":"Worst, average or current pain in the Brief Pain Inventory: which should be used to calculate the response to palliative radiotherapy in patients with bone metastases?","volume":"19","author":"Harris","year":"2007","journal-title":"Clin Oncol"},{"key":"2023010808111344800_bjd21821-bib-0031","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1016\/S0304-3959(01)00349-9","article-title":"Clinical importance of changes in chronic pain intensity measured on an 11-point numerical pain rating scale","volume":"94","author":"Farrar","year":"2001","journal-title":"Pain"},{"key":"2023010808111344800_bjd21821-bib-0032","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1016\/S0304-3959(00)00339-0","article-title":"Defining the clinically important difference in pain outcome measures","volume":"88","author":"Farrar","year":"2000","journal-title":"Pain"},{"key":"2023010808111344800_bjd21821-bib-0033","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1016\/j.pain.2009.08.019","article-title":"Interpreting the clinical importance of group differences in chronic pain clinical trials: IMMPACT recommendations","volume":"146","author":"Dworkin","year":"2009","journal-title":"Pain"},{"issue":"2 Suppl","key":"2023010808111344800_bjd21821-bib-0034","doi-asserted-by":"crossref","first-page":"S106","DOI":"10.1097\/00002508-200006001-00018","article-title":"What is clinically meaningful: outcome measures in pain clinical trials","volume":"16","author":"Farrar","year":"2000","journal-title":"Clin J Pain"},{"key":"2023010808111344800_bjd21821-bib-0035","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1136\/ard.2009.107805","article-title":"Responder analysis for pain relief and numbers needed to treat in a meta-analysis of etoricoxib osteoarthritis trials: bridging a gap between clinical trials and clinical practice","volume":"69","author":"Moore","year":"2010","journal-title":"Ann Rheum Dis"},{"key":"2023010808111344800_bjd21821-bib-0036","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1136\/bmj.310.6977.452","article-title":"The number needed to treat: a clinically useful measure of treatment effect","volume":"310","author":"Cook","year":"1995","journal-title":"BMJ"},{"key":"2023010808111344800_bjd21821-bib-0037","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1016\/j.pain.2003.08.001","article-title":"Core outcome domains for chronic pain clinical trials: IMMPACT recommendations","volume":"106","author":"Turk","year":"2003","journal-title":"Pain"},{"key":"2023010808111344800_bjd21821-bib-0038","doi-asserted-by":"crossref","first-page":"4046","DOI":"10.3390\/jcm9124046","article-title":"Prevalence of neuropathic pain and related characteristics in hidradenitis suppurativa: a cross-sectional study","volume":"9","author":"Garcovich","year":"2020","journal-title":"J Clin Med"},{"key":"2023010808111344800_bjd21821-bib-0039","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1111\/bjd.18656","article-title":"Pain perception in patients with hidradenitis suppurativa","volume":"182","author":"Nielsen","year":"2020","journal-title":"Br J Dermatol"},{"key":"2023010808111344800_bjd21821-bib-0040","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1001\/jamadermatol.2020.0225","article-title":"Chronic pain in hidradenitis suppurativa explained through the process of central sensitization","volume":"156","author":"van Straalen","year":"2020","journal-title":"JAMA Dermatol"},{"key":"2023010808111344800_bjd21821-bib-0041","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1007\/s11916-017-0647-3","article-title":"Pain, psychological comorbidities, disability, and impaired qualify of life in hidradenitis suppurativa [corrected]","volume":"21","author":"Patel","year":"2017","journal-title":"Curr Pain Headache Rep"},{"key":"2023010808111344800_bjd21821-bib-0042","doi-asserted-by":"crossref","first-page":"1911","DOI":"10.1185\/030079906X132488","article-title":"painDETECT: a new screening questionnaire to identify neuropathic components in patients with back pain","volume":"22","author":"Freynhagen","year":"2006","journal-title":"Curr Med Res Opin"},{"key":"2023010808111344800_bjd21821-bib-0043","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1016\/0304-3959(75)90044-5","article-title":"The McGill Pain Questionnaire: major properties and scoring methods","volume":"1","author":"Melzack","year":"1975","journal-title":"Pain"},{"key":"2023010808111344800_bjd21821-bib-0044","doi-asserted-by":"crossref","first-page":"1203","DOI":"10.1111\/bjd.19798","article-title":"Pain Index: a new prospective hidradenitis suppurativa patient-reported outcome measure instrument","volume":"184","author":"Zouboulis","year":"2021","journal-title":"Br J Dermatol"},{"key":"2023010808111344800_bjd21821-bib-0045","author":"Cardiff University"}],"container-title":["British Journal of Dermatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/bjd.21821","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/full-xml\/10.1111\/bjd.21821","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/academic.oup.com\/bjd\/article-pdf\/187\/6\/846\/48529496\/bjd0846.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/bjd\/article-pdf\/187\/6\/846\/48529496\/bjd0846.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,2,14]],"date-time":"2023-02-14T09:14:23Z","timestamp":1676366063000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/bjd\/article\/187\/6\/846\/6972506"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,12,1]]},"references-count":45,"journal-issue":{"issue":"6","published-online":{"date-parts":[[2022,12,1]]},"published-print":{"date-parts":[[2022,12,1]]}},"URL":"https:\/\/doi.org\/10.1111\/bjd.21821","relation":{},"ISSN":["1365-2133","0007-0963"],"issn-type":[{"value":"1365-2133","type":"electronic"},{"value":"0007-0963","type":"print"}],"subject":[],"published-other":{"date-parts":[[2022,12,1]]},"published":{"date-parts":[[2022,12,1]]},"assertion":[{"value":"2021-05-17","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2022-08-11","order":1,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2022-09-04","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}